Liquidia (LQDA) Stock Price
$16.12 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
8
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Liquidia, AI stock picks, stock alerts and much more.
LQDA AI Stock Analysis
AI stock analysis for LQDA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Liquidia (LQDA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Liquidia (LQDA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Liquidia (LQDA), currently trading at $16.12, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About LQDA
-
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
-
Symbol
LQDA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.4B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
LQDA Alternative Data
Web Traffic
Liquidia receives an estimated 6197 monthly visitors to liquidia.com.
-
Web Traffic
6197
-
Change from Previous Month
14.2%
-
3 Month Change
4.8%
News Mentions
Liquidia was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Reddit Mentions
Liquidia has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Liquidia has 883 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.7% over the last month.
-
Twitter Followers
883
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
6.9%
LinkedIn Followers
8,151 are following Liquidia on LinkedIn, up by 7.3% over the last month.
-
LinkedIn Followers
8151
-
Daily Change
0.3%
-
1 Month Change
7.3%
-
3 Month Change
10.6%
Job Postings
Liquidia currenly has an estimated 15 open job postings, up by 15.4% over the last month.
-
Job Postings
15
-
Daily Change
0%
-
1 Month Change
15.4%
-
3 Month Change
650%
LinkedIn Employees
According to LinkedIn, Liquidia has 164 employees.
-
LinkedIn Employees
164
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
-
Business Outlook
27
-
Change from Previous Month
20.6%
-
3 Month Change
0%
-
YoY Change
0%
LQDA Financials
LQDA Key Metrics
-
Total Revenue
$4.4M
-
Net Income
-$23.2M
-
Earnings per Share
-$0.3
-
Free cash flow
-$26.8M
-
EBITDA
-$19.5M
-
EBITDA Ratio
-4.39501
-
Total Assets
$252.9M
LQDA 2-year Revenue & Income
LQDA 2-year Free Cash Flow
LQDA Technicals
LQDA SMA
LQDA RSI
FAQ
What's the current price of Liquidia (LQDA) Stock?
The price of an Liquidia (LQDA) share is $16.12.
What's the market cap of Liquidia?
The current market cap of Liquidia is 1.4B.
Should I buy or sell LQDA?
Liquidia shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Liquidia is better viewed as a hold or accumulate position while waiting for further developments.
Is Liquidia a good investment?
The current analysis of Liquidia's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Liquidia's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Liquidia (LQDA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Liquidia stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Liquidia (LQDA) that investors often compare it to?
Liquidia (LQDA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Liquidia's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Liquidia's stock price to be around $16.19 in 2026. Starting from the current price of $16.12, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Liquidia (LQDA) Stock?
Liquidia stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Liquidia shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.